Hypersensitivity reactions to vaccine components

Dermatitis

Volumn 16, Issue 3, 2005, Pages 115-120

  Heidary, Noushin ^a   Cohen, David E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENOXYETHANOL; ALLERGEN; ALUMINUM; ANTHRAX VACCINE; BIAVAXII; CHICKENPOX VACCINE; CHOLERA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPLOID CELL VACCINE; DRUG PRESERVATIVE; FORMALDEHYDE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LYME DISEASE VACCINE; M R VAXII; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MMR II; MUMPS VACCINE; NEOMYCIN; PETROLATUM; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; RECOMBINANT HEPATITIS B VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; THIOMERSAL; TYPHOID VACCINE; UNINDEXED DRUG; VACCINE; YELLOW FEVER VACCINE;

AIRWAY OBSTRUCTION; ANAPHYLAXIS; CONTACT DERMATITIS; CONTACT SENSITIVITY; DELAYED HYPERSENSITIVITY; DIPHTHERIA; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; ECZEMA; HAEMOPHILUS INFLUENZAE TYPE B; HAND ECZEMA; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; HYPOPIGMENTATION; INFECTION CONTROL; INFLUENZA; INJECTION SITE DERMATITIS; INJECTION SITE PAIN; INJECTION SITE PRURITUS; LICHENOID ERUPTION; MEASLES; MUMPS; ORBIT DISEASE; PATCH TEST; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; RUBELLA; SKIN ALLERGY; SKIN NODULE; TETANUS; UNITED STATES; URTICARIA; VACCINATION REACTION; VESICULAR RASH;

ALUMINUM; ANTI-INFECTIVE AGENTS; DRUG ERUPTIONS; ETHYLENE GLYCOLS; FORMALDEHYDE; HUMANS; HYPERSENSITIVITY, DELAYED; NEOMYCIN; PHARMACEUTIC AIDS; THIMEROSAL; VACCINES;

EID: 33645099378     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.2310/6620.2005.04043     Document Type: Review

References (35)

1. Physicians' desk reference. 57th ed. Montvale (NJ): Medical Economics; 2003.
2. Madaan A, Maddox DE. Vaccine allergy: diagnosis and management. Immunol Allergy Clin North Am 2003;23:555-88.
3. Fischer T, Rystedt I. A case of contact sensitivity to aluminum. Contact Dermatitis 1982;8:343.
4. Tosti A, Vincenzi C, Peluso AM. Accidental diagnosis of aluminum sensitivity with Finn Chambers. Contact Dermatitis 1990;23:48-9.
5. Frost L, Johansen P, Pedersen S, et al. Persistent subcutaneous nodules in children hyposensitized with aluminum-containing allergen extracts. Allergy 1985;40:368-72.
6. Offit P, Jew R. Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics 2003;112(6 Pt 1):1394-7.
7. Eickhoff TC, Myers M. Conference report: aluminum in vaccines. Vaccine 2002;20:S1-4.
8. Hem SL. Elimination of aluminum adjuvants. Vaccine 2002;20: S40-3.
9. Garcia-Patos V, Pujol RM, Alomar A, et al. Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts. Arch Dermatol 1995;131:1421-4.
10. Frost L, Johansen P, Pederson S, et al. Persistent subcutaneous nodules in children hyposensitized with aluminum-containing allergen extracts. Allergy 1985;40:368-72.
11. Osterballe O. Side effects during immunotherapy with purified grass pollen extracts. Allergy 1982;37:553-62.
12. Veien NK, Mattel T, Justesen O, Norholm A. Aluminum allergy. Contact Dermatitis 1986;15:295-7.
13. Cox NH, Moss C, Forsyth A. Allergy to non-toxoid constituents of vaccines and implications for patch testing. Contact Dermatitis 1988;18:143-6.
14. Suneja T, Belsito DV. Thimerosal in the detection of clinically relevant allergic contact reactions. J Am Acad Dermatol 2001;45: 23-7.
15. Marks JG, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group Patch-Test Results, 1998-2000. Am J Contact Dermal 2003;14:59-62.
16. Pratt MD, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group Patch-Test Results, 2001-2002 study period. Dermatitis 2004;15:176-83.
17. Ockenfels HM, Seemann U, Goos M. Contact allergy in patients with periorbital eczema: an analysis of allergens. Dermatology 1997;195:119-24.
18. Tosti A, Melino M, Bardazzi F. Systemic reactions due to thimerosal. Contact Dermatitis 1986;15:187-8.
19. Maibach H. Acute laryngeal obstruction presumed secondary to thimerosal (merthiolate) delayed hypersensitivity. Contact Dermatitis 1975;1:221-2.
20. Aberer W. Vaccination despite thimerosal sensitivity. Contact Dermatitis 1991;24:6-10.
21. Bruckner AL, Weston WL, Morelli JG. Does sensitization to contact allergens begin in infancy? Pediatrics 2000;105:1-4.
22. Osawa J, Kitamura K, Ikezawa Z, Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Dermatitis 1991;24:178-82.
23. Audicana MT, Munoz D, del Pozo MD, et al. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal. Am J Contact Dermal 2002;13:3-9.
24. Cox NH, Forsyth A. Thimerosal allergy and vaccination reactions. Contact Dermatitis 1988;18:229-33.
25. Crockett RE, Lockey RF. Vaccine hypersensitivity. Immunol Allergy Clin North Am 2001;21:707-43.
26. Fitzgerald KA, Davies A, Russell AD. Mechanism of action of chlorhexidine diacetate and phenoxyethanol singly and in combination against gram-negative bacteria. Microbios 1992;70: 215-30.
27. Komatsu E, Yamazaki H, Abe K, et al. Influence of temperature on the efficacy of 2-phenoxyethanol as a preservative for adsorbed diphtheria-purified pertussis-tetanus combined vaccine. J Health Sci 2002;48:89-92.
28. De Groot AC, Van Ginkel CJ, Weijland JW. Methyldibromoglutaronitrile (Euxyl K 400): an important "new" allergen in cosmetics. J Am Acad Dermatol 1996;35:743-7.
29. Sasseville D. Hypersensitivity to preservatives. Dermatol Ther 2004;17:251-63.
30. Vogt T, Landthaler M, Stolz. W. Generalized eczema in an 18-month-old boy due to phenoxyethanol in DPT vaccine. Contact Dermatitis 1998;38:50-1.
31. Til HP, Woutersen RA, Feron VJ, et al. Two-year drinking-water study of formaldehyde in rats. Food Chem Toxicol 1989;27:77-87.
32. Ring J. Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patient. Lancet 1986;2:522-3.
33. Kwittken PL, Rosen S, Sweinberg SK. MMR vaccine and neomycin allergy. Am J Dis Child 1993;147:128-9.
34. Physicians' desk reference. 55th ed. Montvale (NJ): Medical Economics; 2001.
35. Watson JC, Peter G. General immune practices. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd ed. Philadelphia: WB Saunders; 1999. p. 47-73.